Home Characterization and comparative 3D modeling of CmPI-II, a novel ‘non-classical’ Kazal-type inhibitor from the marine snail Cenchritis muricatus (Mollusca)
Article
Licensed
Unlicensed Requires Authentication

Characterization and comparative 3D modeling of CmPI-II, a novel ‘non-classical’ Kazal-type inhibitor from the marine snail Cenchritis muricatus (Mollusca)

  • Yamile González , Tirso Pons , Jeovanis Gil , Vladimir Besada , Maday Alonso-del-Rivero , Aparecida S. Tanaka , Mariana S. Araujo and María A. Chávez
Published/Copyright: November 2, 2007
Biological Chemistry
From the journal Volume 388 Issue 11

Abstract

The complete amino acid sequence obtained by electrospray ionization tandem mass spectrometry of the proteinase inhibitor CmPI-II isolated from Cenchritis muricatus is described. CmPI-II is a 5480-Da protein with three disulfide bridges that inhibits human neutrophil elastase (HNE) (Ki 2.6±0.2 nM), trypsin (Ki 1.1±0.9 nM), and other serine proteinases such as subtilisin A (Ki 30.8±1.2 nM) and pancreatic elastase (Ki 145.0±4.4 nM); chymotrypsin, pancreatic and plasma kallikreins, thrombin and papain are not inhibited. CmPI-II shares homology with the Kazal-type domain and may define a new group of ‘non-classical’ Kazal inhibitors according to its CysI-CysV disulfide bridge position. The 3D model of CmPI-II exhibits similar secondary structure characteristics to Kazal-type inhibitors and concurs with circular dichroism experiments. A 3D model of the CmPI-II/HNE complex provides a structural framework for the interpretation of its experimentally determined Ki value. The model shows both similar and different contacts at the primary binding sites in comparison with the structure of turkey ovomucoid third domain (OMTKY3)/HNE used as template. Additional contacts calculated at the protease-inhibitor interface could also contribute to the association energy of the complex. This inhibitor represents an exception in terms of specificity owing to its ability to strongly inhibit elastases and trypsin.


Corresponding authors ;

Received: 2006-12-11
Accepted: 2007-6-29
Published Online: 2007-11-02
Published in Print: 2007-11-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Proteinase Inhibitors and Biological Control – An Attractive International Symposia Series
  2. Two decades of thyroglobulin type-1 domain research
  3. Cysteine cathepsin non-inhibitory binding partners: modulating intracellular trafficking and function
  4. Cysteine proteases: destruction ability versus immunomodulation capacity in immune cells
  5. ‘Species’ of peptidases
  6. Protease research in the era of systems biology
  7. Human and mouse homo-oligomeric meprin A metalloendopeptidase: substrate and inhibitor specificities
  8. Association of cathepsin E with tumor growth arrest through angiogenesis inhibition and enhanced immune responses
  9. Characterization and comparative 3D modeling of CmPI-II, a novel ‘non-classical’ Kazal-type inhibitor from the marine snail Cenchritis muricatus (Mollusca)
  10. Cellular localization of MAGI-1 caspase cleavage products and their role in apoptosis
  11. Differential methylation kinetics of individual target site strands by T4Dam DNA methyltransferase
  12. Characterisation of zinc-binding domains of peroxisomal RING finger proteins using size exclusion chromatography/inductively coupled plasma-mass spectrometry
  13. Defining the extended substrate specificity of kallikrein 1-related peptidases
  14. Latent MMP-9 is bound to TIMP-1 before secretion
  15. Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma
  16. Activity of ulilysin, an archaeal PAPP-A-related gelatinase and IGFBP protease
  17. Clinical chemistry reference database for Wistar rats and C57/BL6 mice
Downloaded on 17.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2007.129/html
Scroll to top button